Viral Core Proteins

"Viral Core Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins found mainly in icosahedral DNA and RNA viruses. They consist of proteins directly associated with the nucleic acid inside the NUCLEOCAPSID.

Descriptor ID	D014758
MeSH Number(s)	D12.776.964.970.600.850
Concept/Terms	Viral Core Proteins Viral Core Proteins Proteins, Viral Core Virus Core Proteins Core Proteins, Virus Proteins, Virus Core Core Proteins, Viral Core Protein lambda 2 Core Protein lambda 2 Core Protein V Core Protein V Viral Protein P19 Viral Protein P19 Protein P19, Viral OVP 19 Oncornaviral Protein P19 Protein P19, Oncornaviral Major Core Protein lambda-1 Major Core Protein lambda-1 Major Core Protein lambda 1 Major Core Protein sigma-2 Major Core Protein sigma-2 Major Core Protein sigma 2 Major Core Proteins, Viral Major Core Proteins, Viral Major Core Protein Core Protein, Major Protein, Major Core P30 Core Proteins P30 Core Proteins Core Proteins, P30 Proteins, P30 Core Adenovirus Core Protein VII Adenovirus Core Protein VII Influenza Virus Core Proteins Influenza Virus Core Proteins

Below are MeSH descriptors whose meaning is more general than "Viral Core Proteins".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Viral Proteins [D12.776.964]
Viral Structural Proteins [D12.776.964.970]
Nucleocapsid Proteins [D12.776.964.970.600]
Viral Core Proteins [D12.776.964.970.600.850]

Below are MeSH descriptors whose meaning is related to "Viral Core Proteins".

Below are MeSH descriptors whose meaning is more specific than "Viral Core Proteins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Viral Core Proteins" by people in this website by year, and whether "Viral Core Proteins" was a major or minor topic of these publications.

Bar chart showing 9 publications over 9 distinct years, with a maximum of 1 publications in 2002 and 2004 and 2005 and 2006 and 2007 and 2011 and 2014 and 2015 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	1	1
2004	0	1	1
2005	0	1	1
2006	0	1	1
2007	1	0	1
2011	0	1	1
2014	0	1	1
2015	1	0	1
2016	1	0	1

Below are the most recent publications written about "Viral Core Proteins" by people in Profiles.

Ludgate L, Liu K, Luckenbaugh L, Streck N, Eng S, Voitenleitner C, Delaney WE, Hu J. Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation. J Virol. 2016 06 15; 90(12):5830-5844.

View in: PubMed
Kohli A, Funk E, Burbelo P, Barrett L, Meissner EG, Santich B, Shaffer A, Johl J, Sidharthan S, Moir S, Kottilil S, Fauci AS. Persistently elevated abnormal B-cell subpopulations and anti-core antibodies in patients co-infected with HIV/HCV who relapse. J Med Virol. 2015 Apr; 87(4):544-52.

View in: PubMed
King TH, Kemmler CB, Guo Z, Mann D, Lu Y, Coeshott C, Gehring AJ, Bertoletti A, Ho ZZ, Delaney W, Gaggar A, Subramanian GM, McHutchison JG, Shrivastava S, Lee YJ, Kottilil S, Bellgrau D, Rodell T, Apelian D. A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. PLoS One. 2014; 9(7):e101904.

View in: PubMed
Pokrovskii MV, Bush CO, Beran RK, Robinson MF, Cheng G, Tirunagari N, Fenaux M, Greenstein AE, Zhong W, Delaney WE, Paulson MS. Novel mutations in a tissue culture-adapted hepatitis C virus strain improve infectious-virus stability and markedly enhance infection kinetics. J Virol. 2011 Apr; 85(8):3978-85.

View in: PubMed
Heipertz RA, Miller TG, Kelley CM, Delaney WE, Locarnini SA, Isom HC. In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication. J Virol. 2007 Apr; 81(7):3068-76.

View in: PubMed
Zook MB, Howard MT, Sinnathamby G, Atkins JF, Eisenlohr LC. Epitopes derived by incidental translational frameshifting give rise to a protective CTL response. J Immunol. 2006 Jun 01; 176(11):6928-34.

View in: PubMed
Semmo N, Barnes E, Taylor C, Kurtz J, Harcourt G, Smith N, Klenerman P. T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors. Lancet. 2005 Jan 22-28; 365(9456):327-9.

View in: PubMed
Sun BS, Pan J, Clayton MM, Liu J, Yan X, Matskevich AA, Strayer DS, Gerber M, Feitelson MA. Hepatitis C virus replication in stably transfected HepG2 cells promotes hepatocellular growth and tumorigenesis. J Cell Physiol. 2004 Dec; 201(3):447-58.

View in: PubMed
Golovina TN, Wherry EJ, Bullock TN, Eisenlohr LC. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum. J Immunol. 2002 Mar 15; 168(6):2667-75.

View in: PubMed
Hooper DC, Pierard I, Modelska A, Otvos L, Fu ZF, Koprowski H, Dietzschold B. Rabies ribonucleocapsid as an oral immunogen and immunological enhancer. Proc Natl Acad Sci U S A. 1994 Nov 08; 91(23):10908-12.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement